Stock AHEALTH APEX HEALTHCARE
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Apex Healthcare

Equities

AHEALTH

MYL7090OO003

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
2.94 MYR +1.73% Intraday chart for Apex Healthcare +3.52% +18.07%
May. 15 Apex Healthcare Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 15 Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The company is in a robust financial situation considering its net cash and margin position.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • With a 2024 P/E ratio at 22.72 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
APEX HEALTHCARE Stock Apex Healthcare
+18.07% 450M -
MCKESSON CORPORATION Stock McKesson Corporation
+26.77% 76.29B
C+
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-2.27% 23.99B
C+
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+10.27% 9.01B
C
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+12.25% 8.67B
B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-24.34% 7.58B
B-
H. LUNDBECK A/S Stock H. Lundbeck A/S
+12.70% 5.18B
B-
GALENICA AG Stock Galenica AG
+2.89% 4.16B
B
EBOS GROUP LIMITED Stock EBOS Group Limited
-4.96% 3.98B
B-
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
-1.36% 3.63B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. AHEALTH Stock
  4. Ratings Apex Healthcare